Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 17 results found. Search for [ MSD Pharma ]

Results 1 to 17 of 17
April 6, 2018

By P.B. Jayakumar
Delhi, July 27, 2016
But nothing sticks in public memory more than his most recent avatar - Ajay Piramal, the investor. The contrarian, who is placing big bets on businesses ranging from financial services to healthcare on one hand, and drug discovery and realty on the other.

By Poonam Barua
Delhi, February 20, 2016
Best employers for women will strive to have 40 per cent women in the total workforce, spread across levels.

BT Online
New Delhi, February 15, 2016
The drug major, which had posted a net profit of Rs 395.33 crore during the same period last fiscal year, said that it will 'mutually wind down' its joint venture with MSD Pharma's wholly-owned subsidiaries.

New Delhi, February 12, 2016
The synergy benefits of the Ranbaxy acquisition have begun to reflect in the company's financials, the pharma major's Managing Director Dilip Shanghvi said.

Pritam Pal Singh and Hary M Pillai
New Delhi, January 2, 2016
The Delhi High Court in 2015 also rapped the Centre for its coal auction ordinance by saying that the legislation \"lacked clarity\".

BT Online
New Delhi, October 8, 2015
The stock slipped after the Delhi High Court restrained pharma major from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met.

P.B. Jayakumar
August 2, 2015
Frank Stangenberg-Haverkamp, the chief of E. Merck KG, shares his views with P.B. Jayakumar on the company's plans to focus on cancer research and their recipe for growth. Excerpts-

Mail Today Bureau
New Delhi, March 21, 2015
The court barred the pharma company from making, marketing or selling its anti-diabetes medicines on the ground that it had prima facie infringed the patent of Merck Sharp and Dohme (MSD).

E. Kumar Sharma
December 7, 2013
There are more than a dozen drugs in important cancer treatment areas that are not available in India. The new drug flow into India has slowed down significantly and it is a matter of concern for oncologists and cancer patients.

New Delhi, July 19, 2013
Drug major Lupin said it has inked an in-licensing agreement with pharma company MSD, under which the company will market MSD's pneumonia prevention vaccine under a different brand name in India.

New Delhi, April 10, 2013
The US pharmaceuticals major is fighting a single judge bench order refusing to restrain Glenmark Pharmaceuticals from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.

New Delhi, April 9, 2013
US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.

New Delhi, April 5, 2013
The Delhi High Court refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals on manufacturing and marketing anti-diabetes drugs Zita and Zita-Met.

April 25, 2011
Under the pact, which comes nearly two weeks after the two firms had agreed to form a joint venture, Sun will have the rights to sell two drugs in the Indian market.

Mumbai, April 11, 2011
Indian pharma major Sun Pharmaceutical Industries on Monday announced a 50:50 strategic joint venture partnership with global drugmaker Merck and Co Inc to develop, manufacture and commercialise new innovative drugs in emerging markets over the next 2-3 years.
May 1, 2008
Merck India’s doctor-CEO is a man in a hurry.